COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS
|
|
|
- Hester Dawson
- 6 years ago
- Views:
Transcription
1 COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS
2 MITOCHONDRIAL DISORDERS NGS PANELS MITOCHONDRIAL DISORDERS NGS PANELS Name Test code Gene Name Mitome200-Nuclear 2086 (164 nuclear genes) AARS2, ACACA, ACACB, ACAD9, ACADL, ACADM, ACADVL, ACAT1, ADCK3, AGL, ARG1, ATP5A1, ATP5E, ATPAF2, AUH, BCS1L, BTD, C10orf2, C12orf65, COQ2, COQ9, COX15, COX4I1, COX4I2, COX6B1, COX7A1, CPS1, CPT1A, CPT1B, CPT2, DARS2, DGUOK, DLAT, DLD, ETFA, ETFB, ETFDH, ETHE1, FARS2, FASTKD2, FBXL4, FOXRED1, G6PC, GAA, GBE1, GFM1, GYS1, GYS2, HADHA, HADHB, HARS2, HLCS, ISCU, IVD, KARS, LARS2, LMBRD1, LPIN1, LRPPRC, MARS2, MCCC1, MCCC2, MGME1, MMAA, MMAB, MMACHC, MMADHC, MPI, MPV17, MRPL40, MRPL44, MRPS16, MRPS18A, MRPS2, MRPS22, MRRF, MTFMT, MTRR, MUT, NAGS, NARS2, NDUFA1, NDUFA10, NDUFA11, NDUFA13, NDUFA2, NDUFA7, NDUFA8, NDUFAF2, ND- UFAF5, NDUFB6, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV3, NUBPL, OPA1, OPA3, OTC, PC, PCCA, PCCB, PDHA1, PDHB, PDHX, PDP1, PDSS1, PDSS2, PFKM, PGAM2, PGM1, PHKA1, PHKA2, PHKB, PHKG2, PMM2, POLG, POLG2, PUS1, PYGL, PYGM, RARS2, RRM2B, SARS2, SCO1, SCO2, SDHAF1, SDHAF2, SDHB, SDHC, SLC22A5, SLC25A13, SLC25A15, SLC25A19, SLC25A20, SLC25A3, SLC25A4, SLC37A4, SUCLA2, SUCLG1, SUCLG2, SURF1, TACO1, TAZ, TCN2, TFAM, TFB1M, TIMM8A, TK2, TMEM70, TOMM20, TRMU, TSFM, TUFM, TYMP, UQCRB, UQCRQ, YARS2 Leigh Syndrome- Nuclear (91 nuclear genes) (plus mitochondrial genome) AARS2, ACAD9, ADCK3, APTX, ATP5E, ATPAF2 (ATP12), BCS1L, C10ORF2, COQ2, COQ9, COX10, COX15, COX4I1, COX4I2, COX6B1, COX7A1, DARS2, DGUOK, DLAT, DLD, ETFDH, ETHE1, FASTKD2, FH, FOXRED1, GFER, GFM1, LARS2, LMBRD1, LRPPRC, MPV17, MRPS16, MTFMT, NDUFA1, NDUFA10, NDUFA11, NDUFA13, NDUFA2, NDUFA7, NDUFA8, NDUFAF1, NDUFAF2, NDUFAF3, NDUFAF4, NDUFB6, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV3, NUBPL, PC, PDHA1, PDHB, PDHX, PDP1, PDSS1, PDSS2, POLG, RARS2, RRM2B, SCO1, SCO2, SDHA, SDHAF1, SDHAF2, SDHB, SDHC, SDHD, SUCLA2, SUCLG1, SUCLG2, SURF1, TACO1, TK2, TMEM70, TOMM20, TRMU, TSFM, TTC19, TUFM, TUSC3, TYMP, UQCRB, UQCRQ, YARS2 CoQ10 Deficiency 2100 (5 genes) ADCK3 (COQ8/CABC1), COQ2, COQ9, PDSS1, PDSS2
3 Name Test code Gene Name mtdna Depletion/ Integrity Progressive External Ophthalmoplegia (PEO) Chain Complex I V Chain Complex I 2130 (20 genes) 2140 (6 genes) 2180 (50 genes) 2155 (25 genes) APTX, C10orf2, DGUOK, DNA2, FBXL4, GFER, MGME1, MPV17, OPA1, OPA3, POLG, POLG2, RRM2B, SLC25A4, SPG7, SUCLA2, SUCLG1, SUCLG2, TK2, TYMP C10orf2, OPA1, POLG, POLG2, RRM2B, SLC25A4 All genes as listed below for Mitochondrial Respiratory Chain Complex I - V tests FOXRED1, NDUFA1, NDUFA2, NDUFA7, NDUFA8, NDUFA10, NDUFA11, NDUFA13, NDUFAF1, NDU- FAF2, NDUFAF3, NDUFAF4, NDUFAF5 (C20ORF7), NDUFB6, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV3, NUBPL MITOCHONDRIAL DISORDERS NGS PANELS Chain Complex II Chain Complex III Chain Complex IV Chain Complex V PDH & Mitochondrial Respiratory Chain Complex V 2160 (6 genes) 2165 (4 genes) 2170 (12 genes) 2175 (3 genes) 2185 (9 genes) SDHA, SDHAF1, SDHAF2, SDHB, SDHC, SDHD BCS1L, TTC19, UQCRB, UQCRQ COX10, COX15, COX4I1, COX4I2, COX6B1, COX7A1, FASTKD2, LRPPRC, SCO1, SCO2, SURF1, TACO1 ATP5E, ATPAF2 (ATP12), TMEM70 ATP5E, ATPAF2 (ATP12), DLAT, DLD, PDHA1, PDHB, PDHX, PDP1, TMEM70 * Single gene Sanger Sequencing and Targeted Deletion/Duplication analysis are also available. TECHNICAL INFORMATION SAMPLE & SHIPPING INFORMATION Methodology: Test Type: Targeted Capture followed by Massively Parallel Sequencing Next Generation Sequencing SAMPLE & SHIPPING INFORMATION Blood Draw blood in an EDTA (purple-top) tube(s) and send 3-5 cc (Adults/ Children). Sample must arrive within 48 hrs. Purified DNA Send 5-10 ug of purified DNA (minimal concentration of 50ng/uL; A260/A280 of ~1.7). Turn Around Time: 6-10 weeks SHIPPING ADDRESS 2450 Holcombe, Grand Blvd. Receiving Dock, Houston, TX
4 METABOLIC DISORDERS Name Test code Number of Genes Gene name* Cholestasis/PFIC Cobalamin Metabolism Disorders Congenital Disorders of Glycosylation (CDG) CoQ10 Deficiency ABCB4, ABCB11, AKR1D1, ATP8B, JAG1, SLC25A13, SERPINA1 ABCD4, ACSF3, CBS, CD320, GIF, HCFC1, IVD, LMBRD1, MCEE, MMAA, MMAB, MMACHC, MMADHC, MTR, MTRR, MUT, SUCLA2, SUCLG1, SUCLG2, TCN2 ALG1, ALG2, ALG3, ALG6, ALG8, ALG9, ALG11, ALG12, ALG13, ATP6V0A2, B4GALT1, COG1, COG4, COG5, COG6, COG7, COG8, DDOST, DOLK, DPAGT1, DPM1, DPM3, GNE, MGAT2, MOGS, MPDU1, MPI, NGLY1, PMM2, RFT1, SLC35A1, SLC35A2, SLC35C1, SRD5A3, TMEM165, TUSC3 ADCK3 (COQ8/CABC1), COQ2, COQ9, PDSS1, PDSS2 METABOLIC DISORDERS Fatty Acid Oxidation Deficiency Glycogen Storage Disease (GSD) Comprehensive Glycogen Storage Disease (GSD) Liver Glycogen Storage Disease (GSD) Muscle Hemochromatosis Hyperinsulinism Ketotic Hypoglycemia & Gluconeogenesis 3-Methylcrotonyl- CoA Carboxylase (3MCC) Maple Syrup Urine Disease (MSUD) Maturity Onset Diabetes of the Young (MODY) Methylmalonic Acidemia Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) ACAD9, ACADL, ACADM, ACADS, ACADVL, CPT1A, CPT1B, CPT2, ETFA, ETFB, ETFDH, GLUD1, HADH, HADHA, HADHB, HMGCL, HMGCS2, HSD17B10, LPIN1, SLC22A5, SLC25A20, TAZ AGL, FBP1, G6PC, GAA, GBE1, GYG1, GYS1, GYS2, LAMP2, LDHA, PCK1, PCK2, PFKM, PGAM2, PGM1, PHKA1, PHKA2, PHKB, PHKG2, PYGL, PYGM, SLC2A2, SLC37A4 AGL, FBP1, G6PC, GAA, GBE1, GYS2, PCK1, PHKA2, PHKB, PHKG2, PYGL, SLC2A2, SLC37A4 AGL, GAA, GYG1, GYS1, LAMP2, LDHA, PCK2, PFKM, PGAM2, PGM1, PHKA1, PHKB, PYGM HAMP, HFE, HFE2, SLC40A1, TFR ABCC8, GCK, GLUD1, HADH, HNF4A, INSR, KCNJ11, SLC16A ALDOB, FBP1, GYS2, PC MCCC1, MCCC BCKDHA, BCKDHB, DBT, DLD ABCC8, AKT2, BLK, CISD2, CP, EIF2AK3, FOXP3, GATA6, GCK, GLIS3, HNF1A, HNF1B, HNF4A, IER3IP1, INS, KCNJ11, KLF11, NEUROD1, NEUROG3, PAX4, PDX1, PTF1A, RFX6, SLC2A2, WFS MUT, MMAA, MMAB ETFA, ETFB, ETFDH
5 Name Test code Number of Genes Gene name* Myopathy/ Rhabdomyolysis Peroxisomal Disorders ACAD9, ACADL, ACADM, ACADVL, AGL, C10orf2, CPT1B, CPT2, GAA, GYS1, HADHA, HADHB, LPIN1, OPA1, OPA3, PFKM, PGAM2, PGM1, PHKA1, POLG, POLG2, PYGM, RRM2B, SLC22A5 (OCTN2), SUCLA2, TK2, TYMP ACOX1, AGPS, AMACR, DNM1L, GNPAT, HSD17B4, PEX1, PEX2, PEX3, PEX5, PEX6, PEX7, PEX10, PEX11B, PEX12, PEX13, PEX14, PEX16, PEX19, PEX26, PHYH, SCP2 Propionic Acidemia PCCA, PCCB Proximal Urea Cycle Disorders Trifunctional Protein Deficiency CPS1, NAGS, OTC HADHA, HADHB UCD and Hyperammonemia *Single gene Sanger Sequencing and Targeted Deletion/Duplication analysis are also available. TECHNICAL INFORMATION Methodology: Test Type: SAMPLE & SHIPPING INFORMATION Targeted Capture followed by Massively Parallel Sequencing Next Generation Sequencing ARG1, ASL, ASS1, CPS1, NAGS, OTC, SLC25A13, SLC25A15 METABOLIC DISORDERS SAMPLE & SHIPPING INFORMATION Blood Draw blood in an EDTA (purple-top) tube(s) and send 3-5 cc (Adults/ Children). Sample must arrive within 48 hrs. Purified DNA Send 5-10 ug of purified DNA (minimal concentration of 50ng/uL; A260/A280 of ~1.7). Turn Around Time: 6-10 weeks SHIPPING ADDRESS 2450 Holcombe, Grand Blvd. Receiving Dock, Houston, TX
6 MITOCHONDRIAL DISORDERS Name Gene name* Mitochondrial respiratory chain enzyme analysis (ETC) Skeletal Muscle 3200 Skin Fibroblasts 3210 Mitochondrial DNA copy number analysis Skeletal Muscle 3700 Liver 3720 Mitochondrial/Metabolic (MitoMet Plus) Microarray Analysis: Copy number analysis of the entire mtdna and 1635 nuclear genes Advanced mtdna Point Mutations and Deletions by Massively Parallel Sequencing Screens for mtdna deletions and 36 point mutations in MELAS, MERRF, NARP, Leigh Syndrome, LHON, Cardiomyopathy, Deafness and/or Diabetes, Pearson Syndrome, and Kearns-Sayre Syndrome Comprehensive mtdna analysis by next generation sequencing (MitoNGS) MitoNGS is able to detect and quantify heteroplasmic single nucleotide changes down to as low as 1.5% and determine the exact breakpoints of deletions in the mitochondrial genome *Single gene Sanger Sequencing and Targeted Deletion/Duplication analysis are also available. MITOCHONDRIAL DISORDERS
7 SAMPLE & SHIPPING INFORMATION TECHNICAL INFORMATION Blood (accepted for test codes 2010, 2055 and 2000) Draw blood in an EDTA (purple-top) tube(s) and send 3-5 cc (Adults/Children) and 3 cc (Infant<2yrs). Purified DNA (accepted for test codes 2010, 2055 and 2000) Send at least 5ug of purified DNA (minimal concentration of 50ng/uL; A260/A280 of ~1.7). Skeletal Muscle (accepted for test codes 3200, 3700, 2010, 2055 and 2000) 50mg for Muscle Skeletal Muscle should be flash frozen in liquid nitrogen at collection with no media added, stored at -80C, and shipped by overnight courier on 3-5 lbs of dry ice. Liver (accepted for test codes 3720, 2010 and 2055) 50mg for Liver Fresh Tissue should be flash frozen in liquid nitrogen at collection with no media added, stored at -80C, and shipped by overnight courier on 3-5 lbs of dry ice. Cultured Skin Fibroblasts(accepted for test codes 3210, 2010, 2055 and 2000) Send 1-3 T25 flasks at 60-80% confluence. SHIPPING ADDRESS 2450 Holcombe, Grand Blvd. Receiving Dock, Houston, TX MITOCHONDRIAL DISORDERS
8 itochondrial disorders are a group of genetically and clinically heterogeneous multi-systemic disorders. The Mitochondrial laboratory offers the most comprehensive molecular DNA analysis of the common point mutations and large deletions in the mitochondrial genome, the whole mitochondrial genome sequence analysis, and DNA sequence analysis of nuclear genes that are involved in mitochondrial DNA biosynthesis, respiratory chain enzyme complexes assembly, and metabolic disorders, including urea cycle, fatty acid oxidation, creatine pathway, etc. In addition, the laboratory offers the MitoMet oligonucleotide array CGH for the detection of copy number changes in both nuclear and mitochondrial genomes. Shipping Information: Fill out the appropriate laboratory requisition form - an incomplete form will delay testing. Go to to see specific specimen requirements and shipping conditions. Label all specimen tubes with full name and date of birth of the patient. Provide billing information. If we are billing patient insurance, provide a copy of the front and back of the insurance card. For additional information, contact the laboratories at or GENE (4363). Sample Shipping Address: Baylor Miraca Genetics Laboratories 2450 Holcombe, Grand Blvd. Receiving Dock, Houston, TX 77021
9 2450 Holcombe Boulevard Suite O-100, Houston, Texas GENE (4363) Holcombe Boulevard, Suite 0-100, Houston, Texas GENE (4363) or
Mitochondrial Disorders Genetic Testing
Mitochondrial Disorders Genetic Testing A Comprehensive Guide 1 Introduction Mitochondrial disorders are a group of related, clinically diverse, genetic diseases with a prevalence of 1/5,000 to 1/8,500
Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS
UNIVERSITY OF MINNESOTA PHYSICIANS OUTREACH LABS MOLECULAR DIAGNOSTICS (612) 273-8445 DATE: TIME COLLECTED: AM PM PCU/CLINIC: DIAGNOSIS (Dx) / DIAGNOSIS CODES (ICD-9) - OUTPATIENTS ONLY (1) (2) SPECIMEN
Subject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained:
TEST PERFORMED Whole exome sequencing (WES) with Focused Diagnostic Panel(s): Neuropathy, Leukodystrophy, Myopathy See below for a complete list of genes analyzed. RESULTS 1 sequence variant with potential
Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:
PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:
INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS
INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS A broad menu covering the vast majority of inherited metabolic disorders that are routinely tested as part of state newborn screening
PRICE AND TEST LIST January 4, 2018 (by Test Code)
Test Code Test Description TAT Price 2018 CPT Codes WHOLE EXOME SEQUENCING WES001 MNG Exome TM Trio Sequencing and Copy Number Analysis + mtdna (Proband + 2 Family Members) 2-4 Weeks $6,900.00 81415, 81416,
PRICE AND TEST LIST August 24, 2018 (by Test Code)
Test Code Test Description TAT Price 2018 CPT Codes WHOLE GENOME SEQUENCING WGS001 MNGenome TRIO Sequencing 2-6 Weeks Call 81425, 81426 x2 WGS003 MNGenome Proband Only Sequencing 2-6 Weeks Call 81425 WHOLE
Utility of Microarrays in Molecular Genetics
Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,
Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:
PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:
Promo Code (if applicable) mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.
tic Diagnostics A. Analysis Requested 1. Test(s)/(s) 1.1 Single Sequencing 1.2 NGS Panel 1.3 NGS Panel Plus 1.4 NGS Panel Genomic 1.5 Deletion/Duplication Analysis B. Patient Name (Label) 1. Surname Promo
Promo Code (if applicable) ... mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.
Genetic Diagnostics A. Analysis Requested 1. Test(s)/Gene(s) 1.1 Single Gene Sequencing 1.2 NGS Panel 1.3 NGS Panel Plus 1.4 NGS Panel Genomic 1.5 Deletion/Duplication Analysis 1.6 Repeat Expansion 1.7
Joshua Hellmann Foundation - Newborn Metabolic Screening Program
Joshua Hellmann Foundation - Newborn Metabolic Screening Program Centre of Inborn Errors of Metabolism The Chinese University of Hong Kong Last update: 11 June 2013 Target inborn errors of metabolism (IEM)
NGS Panel Plus. Sequencing Sequencing + NGS based CNVs Del/Dup with MLPA. Clinic. Department. Street. ZIP Code/Town. Country. . Billing.
Promo Code (if applicable) Genetic Diagnostics (s)/gene(s)/panel(s): Analysis Requested Single Gene Sequencing Sequencing (Sanger) Sequencing (NGS) Sequencing + CNVs (with NGS) Del/Dup (MLPA or qpcr) Carrier
Supplemental Table 1. Cardiac mitochondrial acetyl proteoforms in mouse heart. Uniprot ID Gene Symbol Acetyl Proteoform Q8BWT1 Acaa2 K137 Q8BWT1
Supplemental Table 1. Cardiac mitochondrial acetyl proteoforms in mouse heart. Uniprot ID Gene Symbol Acetyl Proteoform Q8BWT1 Acaa2 K137 Q8BWT1 Acaa2 K171 Q8BWT1 Acaa2 K234 Q8BWT1 Acaa2 K240 D3Z7X0 Acad12
MetBioNet Best Practice Guidelines. Investigation of an inherited metabolic cause of cardiomyopathy
Introduction MetBioNet Best Practice Guidelines Investigation of an inherited metabolic cause of Inborn errors of metabolism (IEM) account for at least 5% of cases of. In some disorders, is the major cause
Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations
Sema4 Natalis Clinical significance of panel Sema4 has designed and validated Natalis, a supplemental newborn screening panel offered for newborns, infants, and young children. This test may be offered
Maturity-onset diabetes of the young (MODY) is a heterogeneous group
Over the years, different forms of maturity-onset diabetes of the young (MODY) have been identified, with mutations in a number of different genes associated with a MODY-like phenotype. Depending on the
devact TM Clinical Management Panel for Neurodevelopmental Disorders
Amino acid disorder AMT Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GCSH Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GLDC Glycine encephalopathy
Referring Physician Information Name: (Last, First, Middle):
Page 1 of 5 Patient Information Clinical Indication: Patient Name: (Last, First, Middle): DOB (M/D/Y): Sex: M F Guardian Name (for minor patients only): Address: City: State: ZIP: Phone: Ethnic Background
Brain MRI in Mitochondrial Disorders: Correlating the Phenotype with the Genotype. Bindu Parayil Sankaran
Brain MRI in Mitochondrial Disorders: Correlating the Phenotype with the Genotype Bindu Parayil Sankaran copyright Bindu Parayil Sankaran, Maastricht 2018 Printing: Datawyse Universitaire Pers Maastricht
Mitochondrial disorders are among the most severe
NEUROLOGY GRAND ROUNDS Leigh Map: A Novel Computational Diagnostic Resource for Mitochondrial Disease Joyeeta Rahman, BSc, 1 Alberto Noronha, MSc, 2 Ines Thiele, PhD, 2 and Shamima Rahman, FRCP, PhD 1,3
Related Policies None
Medical policy MP 2.04.117 BCBSA Ref. Policy: 2.04.117 Last Review: 06/22/2017 Effective Date: 06/22/2017 Section: Medicine End Date: 06/26/2018 Related Policies None DISCLAIMER Our medical policies are
NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:
NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status
Comprehensive Molecular Testing for Fatty Acid Oxidation Disorders. A Guide for Clinicians
Comprehensive Molecular Testing for Fatty Acid Oxidation Disorders A Guide for Clinicians Cincinnati Children s Hospital Molecular Genetics Laboratory introduces MetaboSeq, our next-generation sequencing
BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related
Geni investigati e patologie associate BabyNEXT TM EXTENDED Gene Disease OMIM gene ABCC8 Familial hyperinsulinism ABCC8-related OMIM Disease Condition 600509 256450 Metabolic disorder - ABCD1 Adrenoleukodystrophy
Address City State Zip Phone. the hospital/facility:
PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:
Assessed Molecular Mechanism of Action of Milagro de la Selva
Assessed Molecular Mechanism of Action of Milagro de la Selva Results A report prepared by Connexios Life Sciences Bangalore 1. Muscle - C2C12 cells. 1.1. Glucose uptake, Glycolysis and Tricarboxylic acid
Whole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future?
Whole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future? Tony Marinakii Purine Research Laboratory Biochemical Sciences Whole exome sequencing No doubt
theraseek Panel Gene List by Category
theraseek Panel Gene List by Category Gene Pathway/Function Association ACAT1 Alpha-methylacetoacetic aciduria Amino acid metabolism Pathway DHTKD1 Charcot-Marie-Tooth disease 2Q, axonal/2-aminoadipic
Newborn Genetic Analysis
Fulgent tics Newborn tic Analysis Newborn tic Analysis (NGA) is a highly sophisticated and sensitive genetic test that identifies DNA changes that can cause infants to develop severe or life-altering conditions.
Enabling Informed Clinical Decisions with Deep Insights. Routine Multi-gene Testing for Inherited Neuromuscular Disorders
Enabling Informed Clinical Decisions with Deep Insights Routine Multi-gene Testing for Inherited Neuromuscular Disorders Introduction Multi-gene Testing for Inherited Neuromuscular Disorders Inherited
NEW TOOLS FOR MITOCHONDRIAL DISEASE DIAGNOSIS: FGF21, GDF15 AND NEXT- GENERATION SEQUENCING
Research Programs Unit for Molecular Neurology Faculty of Medicine Doctoral Programme in Biomedicine University of Helsinki Finland NEW TOOLS FOR MITOCHONDRIAL DISEASE DIAGNOSIS: FGF21, GDF15 AND NEXT-
High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)
CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact
Analysis and interpretation of genetic NEUROLOGICAL DISORDERS
, PH 1, POLG M, RAPSN, R CA, SGCB, SGC A3, SLC25A4, SLC5 1, SYNE2, SYT2, TAC NNT1, TNNT3, T N 4, TRIM63, TRIP4, AS39, VMA21, VPS S, ACADVL, ACTA1, AD 1, ANO5, ASCC1, ATP2A CACNA1S, CAPN3, CASQ P1, COL12A1,
Metabolic Muscle Diseases
Metabolic Muscle Diseases Dr Tim Hutchin, Birmingham Children s Hospital Jan 13, 2012 Metabolic myopathies are heterogeneous conditions with defects of muscle energy metabolism that result in predominantly
Diagnose a broad range of metabolic disorders with a single test, Global MAPS
PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds
Mitochondrial Fatty Acid Oxidation Deficiencies Prof. Niels Gregersen
Mitochondrial Fatty Acid Oxidation Deficiencies Research Unit for Molecular Medicine Clinical Institute Aarhus University Hospital and Faculty of Health Sciences Aarhus University, Aarhus, Denmark 1 Menu
An Introduction to mitochondrial disease.
9 th September 2017 An Introduction to mitochondrial disease. Dr Andy Schaefer Consultant Neurologist and Clinical Lead NHS Highly Specialised Rare Mitochondrial Disease Service and Wellcome Trust Centre
Supplemental Figure 1
Supplemental Figure 1 mir 26a mir 26b Supplemental Figure 1. Expression of mir-26a is higher than mir-26b in the mouse liver. Dot blot analysis of mir-26a/b expression in the livers of wild-type mice fed
The laboratory investigation of lactic acidaemia. J Bonham/T Laing
The laboratory investigation of lactic acidaemia J Bonham/T Laing Reference range Typical ranges for blood lactate are: Newborn 0.3-2.2 mmol/l Nielsen J et al1 1994 1-12mo 0.9-1.8 mmol/l Bonnefont et al
OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018
OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 Please note that there is a 15% surcharge for Non-NHS patients. Highly specialised services (HSS) are indicated. Note: This test
4978 Santa Anita Ave Temple City, CA (p) (f)
Patient Information Doe, Jane Sex: F MR#: FD Patient#: FT-PT00000 Accession: FT-00000 Test#: FT-00000 Specimen Type: Blood (EDTA) Collection Date: Aug 01, 2017 Partner Information Not Tested Accession:
Joshua Hellmann Foundation - Newborn Metabolic Screening Program
Joshua Hellmann Foundation - Newborn Metabolic Screening Program Centre of Inborn Errors of Metabolism The Chinese University of Hong Kong Last update: 15 February 2016 Target inborn errors of metabolism
Informatics Analysis of Genetic Variants in Newborn Screening By Chelsea Gustafson
Informatics Analysis of Genetic Variants in Newborn Screening By Chelsea Gustafson Senior Honors Thesis Biology University of North Carolina at Chapel Hill Approved: Jonathan Berg, Thesis Advisor Terry
EFNS guidelines on the molecular diagnosis of mitochondrial disorders
European Journal of Neurology 2009, 16: 1255 1264 EFNS GUIDELINES/CME ARTICLE doi:10.1111/j.1468-1331.2009.02811.x EFNS guidelines on the molecular diagnosis of mitochondrial disorders J. Finsterer a,
UNIVERSITY OF PENNSYLVANIA GENETIC DIAGNOSTIC LABORATORY
GNA FOP Familial Adenomatous Polyposis Beckwith-Wiedemann Syndrome Methylation and high resolution copy number analysis of 11p15.5 with automatic reflex to CDKN1C if negative Methylation analysis of 11p15.5
For Your Baby s Health Department of Health
Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your
REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First
#: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST
SERVICE SCHEDULE, FEES & GUIDELINES FOR SAMPLE SHIPMENT
SERVICE SCHEDULE, FEES & GUIDELINES FOR SAMPLE SHIPMENT ACYLCARNITINE PROFILE: PLASMA/SERUM, PKU CARD, WHOLE BLOOD Amount of sample: Plasma (heparinized is preferred, EDTA acceptable) or serum: 0.5 ml
LABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS
LABHORIZONS A NEWSLETTER FOR CLIENTS Volume XVII, No. 7 July 2017 New Procedures 5 HIAA, Plasma.................................. 504510 CPT 83497 Synonyms 5-hydroxyindoleacetic acid Use Plasma 5-hydroxy-indoleacetic
Presentation and investigation of mitochondrial disease in children
Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product
HERES Carrier Screening TEST
LISTADO DE ENFERMEDADES ANALIZADAS HERES Carrier Screening TEST 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha-Hydroxylase Deficiency 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency
LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene
LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene ACTA2* Exon 02-09 NM_001613.2 DSG2* Exon 01-15 NM_001943.3 ACTC1* Exon 01-06 NM_005159.4 DSP* Exon 01-24 NM_004415.2 APC* Exon 01-15
Contribution of Nutrients in Complex Inborn Errors of Metabolism: The Case of Methylmalonic Aciduria (MMA)
Contribution of Nutrients in Complex Inborn Errors of Metabolism: The Case of Methylmalonic Aciduria (MMA) Charles P. Venditti, MD, PhD Head, Organic Acid Research Section No conflicts of interest to declare
LISTE DES ANALYSES HORS-QUEBEC List for testing done out of Québec LABORATOIRE CLINIQUES CUSM MUHC CLINICAL LABS
2,3-Dinor-11Beta-Prostaglandin F2 Alpha, Urine [23BPG] LISTE DES ANALYSES HORS-QUEBEC Urine. No preservative. Collect for 24-h or random sample. Refrigeate 4 C during collection. Store frozen. systemic
Role of next generation sequencing in clinical care
Role of next generation sequencing in clinical care Anne Slavotinek Division of Genetics, Department of Pediatrics, UCSF Structure 1. Next generation technologies 2. Consent and secondary findings 3. Genetics
Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius
Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):
Title: Assessing Recommendations Related To Timeliness of Newborn Screening
Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)
SUPPLEMENTARY,INFORMATIONS,,,, mtorc1,is,required,for,brown,adipose,tissue,recruitment,and, METABOLIC,ADAPTATION,TO,COLD,!! Sébastien!M.!
SUPPLEMENTARY,INFORMATIONS,,,, mtorc,is,required,for,brown,adipose,tissue,recruitment,and, METABOLIC,ADAPTATION,TO,COLD, SébastienM.Labbé,,MathildeMouchiroud,,AlexandreCaron,,BlandineSecco,, Elizaveta
UKGTN Testing Criteria
Test name: Neonatal Diabetes 22 Gene Panel UKGTN Testing Criteria Approved name and symbol of disorder/condition(s): See Appendix 1 Approved name and symbol of gene(s): See Appendix 1 number(s): number(s):
Muscle Metabolism. Dr. Nabil Bashir
Muscle Metabolism Dr. Nabil Bashir Learning objectives Understand how skeletal muscles derive energy at rest, moderate exercise, and strong exercise. Recognize the difference between aerobic and anaerobic
McArdle Disease And Related Glycogen Storage Disorders Highly specialized National Service. Ros Quinlivan Taunton 2018
McArdle Disease And Related Glycogen Storage Disorders Highly specialized National Service Ros Quinlivan Taunton 2018 Muscle glycogen metabolism disorders Fixed: muscle weakness GSDII Pompe Disease GSDIII
234 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Received: 2016.09.22 Accepted: 2016.12.23 Published: 2017.03.08 Authors Contribution: Study Design A Data Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search
General Test Requisition Form - Biochemical and Molecular
General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name MM/ DD
Ah Receptor-Mediated Disruption of the Cardiac Embryogenesis Program Alvaro Puga Department of Environmental Health University of Cincinnati College
Ah Receptor-Mediated Disruption of the Cardiac Embryogenesis Program Alvaro Puga Department of Environmental Health University of Cincinnati College of Medicine, Ohio. Source: texasheart.org Congenital
Introduction. Overview
Leigh syndrome Redi Rahmani BA ( Dr. Rahmani of Dartmouth-Hitchcock Medical Center/Geisel School of Medicine at Dartmouth has no relevant financial relationships to disclose. ) Brandon Root MD ( Dr. Root
Illinois AACE Annual Meeting October 13, 2018
Illinois AACE Annual Meeting October 13, 2018 The Importance of Making a Diagnosis: The case for Monogenic Diabetes Louis H. Philipson MD, PhD Director, Kovler Diabetes Center Professor of Medicine and
Baf60c drives glycolytic muscle formation and improves glucose homeostasis through Deptor-mediated Akt activation
Baf6c drives glycolytic muscle formation and improves glucose homeostasis through Deptor-mediated Akt activation Zhuo-Xian Meng,2, Siming Li,2, Lin Wang,2, Hwi Jin Ko 3, Yongjin Lee 3, Dae Young Jung 3,
Robert Barski. Biochemical Genetics St James s University Hospital, Leeds. MetBioNet IEM Introductory Training
Robert Barski Biochemical Genetics St James s University Hospital, Leeds Lactate is produced as the fate of anaerobic metabolism of pyruvate. It is an important intermediary metabolite especially with
# DISEASE GENE GHI CHÚ 1 17-beta-hydroxysteroid dehydrogenase defciency, type HSD17B Hydroxy-3-methylglutaryl-CoA lyase deficiency HMGCL
# DISEASE GENE GHI CHÚ 1 17-beta-hydroxysteroid dehydrogenase defciency, type HSD17B3 III 2 3-Hydroxy-3-methylglutaryl-CoA lyase HMGCL 3 3-hydroxyacyl-CoA dehydrogenase defciency HADH 4 3-hydroxyisobutryl-CoA
General Test Requisition Form - Biochemical and Molecular
General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name Middle
Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels
Targeted s and Methodology Details for Epilepsy/Seizure tic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Epilepsy/Seizure tic Panels Epilepsy Expanded Panel Epilepsy Expanded
Foresight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:
Clinical Management of Organic Acidemias and OAA Natural History Registry. Kim Chapman MD PhD Children s National Rare Disease Institute
Clinical Management of Organic Acidemias and OAA Natural History Registry Kim Chapman MD PhD Children s National Rare Disease Institute Disclosure Nothing to disclose concerning this lecture Organic acid?
COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS
COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS S MELDAU, G VAN DER WATT INHERITED METABOLIC DISEASES GROUP UCT /
TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN
TIMELINESS OF NEWBORN SCREENING: RECOMMENDATIONS FROM ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN Susan Tanksley, PhD May 19, 2015 TIMELINESS - BACKGROUND In order to effectively
The mitochondrion and its disorders
100 PRACTICAL NEUROLOGY H O W T O U N D E R S T A N D I T The mitochondrion and its disorders Patrick F. Chinnery Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and
SALSA MLPA probemix P241-D2 MODY mix 1 Lot D As compared to version D1 (lot D1-0911), one reference probe has been replaced.
mix P241-D2 MODY mix 1 Lot D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent diabetes
Supplementary Figure 1. Mitochondrial function in skeletal muscle and plasma parameters of STZ mice A D-F
Supplementary Figure 1. Mitochondrial function in skeletal muscle and plasma parameters of STZ mice A Expression of representative subunits of the mitochondrial respiratory chain was analyzed by real time
Mitochondrial Diseases
Mitochondrial Diseases Simon Heales SWIM Conference Taunton, November 29 th 2018 Respiratory Failure Cardiomyopathy Optic Atrophy / Retinitis Pigmentosa Seizures / Developmental delay Liver Failure Deafness
Impaired Mitochondrial Biogenesis in Adipose Tissue in Acquired Obesity
Diabetes Volume 64, September 2015 3135 Sini Heinonen, 1 Jana Buzkova, 2 Maheswary Muniandy, 1 Risto Kaksonen, 1,3 Miina Ollikainen, 4 Khadeeja Ismail, 4 Antti Hakkarainen, 5 Jesse Lundbom, 5,6 Nina Lundbom,
Residual risks by ethnicity
Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual
Newborn Screening: Focus on Treatment
Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public
[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995
![[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995](/thumbs/95/122505027.jpg "[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995")
RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.
SALSA MLPA probemix P241-D2 MODY mix 1 Lot D2-0716, D As compared to version D1 (lot D1-0911), one reference probe has been replaced.
mix P241-D2 MODY mix 1 Lot D2-0716, D2-0413. As compared to version D1 (lot D1-0911), one reference has been replaced. Maturity-Onset Diabetes of the Young (MODY) is a distinct form of non insulin-dependent
Mitochondrial Disorders Overview
Mitochondrial Disorders Overview [Mitochondrial Encephalomyopathies, Mitochondrial Myopathies, Oxidative Phosphorylation Disorders, Respiratory Chain Disorders] PMID: 20301403 Patrick F Chinnery, PhD,
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic. Brian R. Wamhoff, 501 Locust Ave., Charlottesville, VA 22902
Supplemental Information Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis Ryan Feaver, Banumathi K Cole, Mark J Lawson, Stephen A Hoang, Svetlana Marukian,
CARRIER SCREENING PANEL
1 / 6 1. WHAT IS THE CARRIER? The carrier screening panel is a genetic test that simultaneously analyses mutations in 298 genes which cause recessive inherited pathologies. Diseases with a recessive inheritance
HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury
J Mol Med 2015 HIF-P4H-2 deficiency protects against skeletal muscle ischemia-reperfusion injury Sara Karsikas; Mikko Myllymäki; Minna Heikkilä; Raija Sormunen; Kari I Kivirikko; Johanna Myllyharju; Raisa
Evolve FamilyReady Carrier Screen
Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy
Non-Lysosomal Glycogen Storage Disorders Biochemical Diagnosis
Non-Lysosomal Glycogen Storage Disorders Biochemical Diagnosis Katie Bainbridge Enzyme Laboratory Great Ormond Street Hospital Glycogen Metabolism Glycogen Glycogen -glucosidase Lysosome Brancher Glycogen
SUPPLEMENTARY INFORMATION
Figure S1. The expression of Plgf, Vegfa, Vegfc or Myh7 generates lower correlation coefficients to the mitochondrial cluster, as compared to Vegfb. The intensity of Plgf, Vegfa, Vegfc and the myocyte
Foresight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4
Clinical Laboratory Fee Schedule CY 2015 Updates June 9, 2014
Clinical Laboratory Fee Schedule CY 2015 Updates June 9, 2014 Please note that this listing includes the most recent codes provided by the American Medical Association (AMA), and that it is subject to
CFSE Thy1.2 + CD4 + cells
Time after immunization (d) IFN-g Spleen Lymph nodes Rbpj +/+ ;OT-II Rbpj -/- ;OT-II Rbpj +/+ ;OT-II Rbpj -/- ;OT-II 2.3.2 22.9 5.6 3 23.3 3. 21.3 32.7 8.7 18.5 11.6 13.5 7 84.2 74.2 85. 83.8 CFSE Thy1.2
Supplementary Materials for
www.sciencesignaling.org/cgi/content/full/6/264/rs4/dc1 Supplementary Materials for A Systems Approach for Decoding Mitochondrial Retrograde Signaling Pathways Sehyun Chae, Byung Yong Ahn, Kyunghee Byun,
Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism
Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Patricia Jones, PhD DABCC FACB UT Southwestern Medical Center Children s Medical Center Dallas, Texas Learning Objectives Justify
Nutritional Interventions in Primary Mitochondrial Disorders
Nutritional Interventions in Primary Mitochondrial Disorders Carolyn J Ellaway MBBS PhD FRACP CGHGSA Genetic Metabolic Disorders Service Sydney Children s Hospital Network Disciplines of Child and Adolescent
Review: Mitochondrial Medicine Cardiomyopathy Caused by Defective Oxidative Phosphorylation
Annals of Clinical & Laboratory Science, vol. 33, no. 4, 2003 371 Review: Mitochondrial Medicine Cardiomyopathy Caused by Defective Oxidative Phosphorylation Egil Fosslien Department of Pathology, College